Centene’s concerns over Medicare market dull Q1 profit beat
Centene said on Friday its Medicare insurance business would face several challenges next year, taking the sheen off a strong first-quarter earnings report from the health insurer.
Centene said on Friday its Medicare insurance business would face several challenges next year, taking the sheen off a strong first-quarter earnings report from the health insurer.
Ashish Kamat and Mark Tyson discuss the currently enrolling PIVOT-006 study. Dr. Tyson discusses cretostimogene grenadenorepvec, a conditionally replicating oncolytic adenovirus designed for cancer cell…
Eli Lilly said on Tuesday a panel of independent U.S. FDA advisers will discuss its experimental Alzheimer’s disease drug, donanemab, on June 10.
German health technology company Siemens Healthineers reported on Tuesday second-quarter revenue growth slightly below consensus expectations, as it was hurt by declining revenue in China.
metastatic castration-sensitive prostate cancer (mCSPC), apalutamide treatment effect in TITAN patients with mCSPC, phase III randomised TITAN study, robust benefit with apalutamide plus ADT.
Tips and resources to help cancer survivors cope with emotional problems.
The ability of odors to bring to mind past experiences has intriguing scientific and therapeutic implications
Shinde et al. establish a community resource to compare patients’ vaccine responses and to host annual contests to predict vaccination outcomes. They find specifically trained multi-omics…
Ruchika Talwar speaks with Chana Weinstock about the recent chemotherapy shortage affecting genitourinary cancers, notably muscle-invasive bladder cancer. Dr. Weinstock explains the complexity behind drug…
Robot-Assisted PSMA-Radioguided Surgery, Prostate Cancer, radical prostatectomy, Confocal microscopy, PSMA PET/CT, 68Ga-PSMA-11, robot-assisted radical prostatectomy (RARP), pelvic lymph node dissection (PLND), AURA 10 specimen PET/CT…
The award marks ProPublica’s 7th Pulitzer; Uvalde shooting investigation is named a Pulitzer finalist.